The role of the thyroid gland in the regulation of metabolic rate has been known since the last century. The knowledge that thyroid hormones increase energy expenditure, in part by lowering metabolic ef®ciency, dates from the 1950s. Presumably thyroid hormones regulate energy expenditure and ef®ciency by controlling the rate of transcription of speci®c genes. However, the number, identity, and relative contributions of these genes are not known. The uncoupling proteins (UCPs) are obvious candidates to mediate thyroid thermogenesis. UCP1 is not a major contributor, since thyrotoxicosis decreases UCP1 expression and inactivates brown fat. Discovery of UCP3 and its regulation by T3 in muscle is an exciting observation, consistent with a role for UCP3 in thyroid thermogenesis. Since free fatty acids appear to regulate UCP3 expression and T3 stimulates lipolysis, further experiments are required to determine if T3 regulation of UCP3 expression is direct or not.
Introduction to thyroid hormones and metabolic rate
The role of the thyroid gland in the regulation of metabolic rate was deduced 100 years ago, 1 and thyroxine, a thyroid hormone, was puri®ed by Kendall 20 years later.
2 Demonstration that thyroid hormones increase energy expenditure by lowering metabolic ef®ciency in addition to increasing rate dates from the 1950s, when it was shown that mitochondria from thyrotoxic rats produced less ATP per mole oxygen consumed. 3, 4 The effect of thyroid hormone on metabolic rate varies between tissues, with oxygen consumption in liver, muscle, and kidney, but not brain or spleen, increasing with thyroid treatment. 5 In liver, approximately half of the effect of thyroid hormone on metabolic rate is due to changes in mitochondrial proton leak. 6 It is remarkable how little we know about the molecular mechanisms by which thyroid hormone decreases metabolic ef®ciency, given the length of time and the intensity of the interest in this question. Discovery of a thyroid hormone receptor (TR) was a major advance. 7, 8 TRs are transcription factors that bind speci®c DNA sequences named thyroid response elements (TREs). Upon binding both a thyroid hormone and a TRE, the TR is activated (or derepressed) and transcription of the regulated gene increases. 9 The idea that thyroid hormone also has non-transcriptional effects is much discussed, but it is likely that most of the metabolic effects of thyroid hormone result from transcriptional regulation. In support of this idea, the metabolic effects of thyroid hormone typically require hours to days for full effect. Additionally, mice lacking functional TRa1 thyroid hormone receptors have a decreased body temperature. 10 Thus it seems reasonable that thyroid hormones decrease energy ef®ciency via TR-mediated transcriptional regulation of speci®c genes.
Possible mechanisms by which thyroid hormone regulates metabolic ef®ciency
Over the years, multiple hypotheses have been formulated to explain the mechanisms by which thyroid hormones change the ef®ciency of energy metabolism (reviewed in References 11 and 12). The glycerol phosphate shuttle is inherently inef®cient (thermogenic), and the activity and mRNA levels of the limiting enzyme, mitochondrial FAD-dependent glycerol-3-phosphate dehydrogenase, are up-regulated by thyroid hormone only in thyroid-responsive tissues. 13, 14 Other proposed mechanisms involve the NaaK-ATPase, Ca-ATPase and ATP synthase.
A different kind of mechanism posits that thyroid hormone's effects on mitochondrial membrane lipid composition and membrane surface area regulate the lipid bilayer's proton permeability (reviewed in Reference 15). To date there is no strong support for a predominant role for any one mechanism. Possible explanations for this unsatisfying understanding of thyroid hormone-induced metabolic inef®ciency include: one of the above mechanisms is a major contributor but has not yet been appreciated as such, many pathways each contribute to a small extent, andaor the quantitatively major mediator(s) have yet to be identi®ed.
Thyroid hormone and uncoupling proteins
Brown adipose tissue's function is to generate heat in response to a cold environment. This is accomplished chie¯y through uncoupling protein-1 (UCP1, previously UCP, 16 which is encoded by a nuclear gene that is expressed only in brown adipose tissue (BAT).
17,18 UCP1 mediates the net transport of protons through the inner mitochondrial membrane, uncoupling substrate oxidation from ATP production. The protein has six predicted transmembrane domains and its activity is inhibited by purine nucleotides 19, 20 and stimulated by free fatty acids. T3 increases the transcription of UCP1, acting at TREs in an enhancer located 2.3 kb upstream of the promoter. 21 However, this action of T3 appears to be only permissive for UCP1 expression, since hyperthyroid animals do not have increased BAT thermogenesis. In fact, in hyperthyroid animals the BAT becomes inactive, with reduced UCP1 expression, suggesting that T3-induced thermogenesis in other tissues reduces the need for BAT thermogenesis. 22 Since UCP1 is unlikely to play a major role in thyroid thermogenesis, the discovery of UCP2 23, 24 and UCP3 25 ± 27 was quite exciting. UCP3 is 73% identical to UCP2, 58% identical to UCP1, and much less similar to other members of the mitochondrial anion carrier family. The sequence similarity suggests that the UCPs have related functions, and UCP2 and UCP3 expression can decrease the mitochondrial membrane potential. 24, 27, 28 We measured UCP mRNAs in skeletal muscle from rats with alterations in their thyroid status. 27 Chronic hypothyroidism decreased the UCP3 RNA levels 3-fold. Treatment of either hypothyroid or euthyroid rats with a single dose of T3 increased UCP3 mRNA levels 4 to 6-fold above euthyroid levels. Rats made hyperthyroid by daily T3 injections for 4 d showed muscle UCP3 expression patterns similar to the single dose experiment. Larkin et al also observed T3 regulation of UCP3 mRNA levels. 29 These data suggested that thyroid hormone is a physiologic regulator of UCP3.
UCP3 in BAT is regulated differently from muscle. In BAT, UCP3 levels were not reduced in hypothyroid rats, and did not increase in euthyroid rats given a single dose of T3, although a 3.5-fold increase in hypothyroid rats treated with T3 was observed. In contrast, no change in UCP2 expression was observed in muscle or BAT with any of these manipulations of thyroid status. These experiments demonstrate that UCP3 is regulated differently in muscle as compared to BAT and suggest that thyroid hormone regulates UCP3 but not UCP2.
Future questions
The observation that fasting, during which energy expenditure drops, causes a robust increase in muscle UCP3 mRNA levels 27, 30 was unexpected, since increased uncoupling activity should increase energy expenditure. A number of interpretations are possible, including muscle assuming a more important role in thermogenesis during fasting and increased muscle futile cycling to allow increased metabolic readiness. The demonstration that free fatty acids (which increase with fasting) can increase muscle UCP3 mRNA levels, led to the suggestion that UCP3 plays a role in fatty acid metabolism. 31 This hypothesis ®ts much of the data on the regulation of UCP3. Conditions with high fatty acid metabolic rates tend to have higher UCP3 mRNA levels, and vice versa. For example, we recently developed a mouse lacking white fat, a model for lipoatrophic diabetes. 32 In these mice, which do not increase their free fatty acids upon fasting, muscle UCP3 mRNA levels do not rise, supporting a role for free fatty acids in UCP3 regulation (Gavrilova et al, manuscript submitted). Acute thyroid hormone treatment causes lipolysis, 33 and could thus explain the observed increased UCP3 mRNA levels. Does thyroid hormone directly regulate UCP3 transcription, or are its effects mediated through free fatty acid (or metabolite) levels or uxes? These observations suggest two avenues for future investigation. What role do free fatty acids have in regulating UCP3 expression, and what role does UCP3 have in free fatty acid metabolism?
Free fatty acids might directly regulate UCP3 transcription, for example by binding to ligand-regulated transcription factors. Peroxisome proliferatoractivated receptors (PPARs) are transcription factors that are activated upon binding fatty acid ligands; it is likely that some of the less well characterized homologous proteins (`orphan nuclear receptors') also do this. 34, 35 The fatty acid may require metabolism before being able to regulate transcription, or may be an indirect regulator.
The possible role of UCP3 in free fatty acid metabolism is currently unexplored. The UCPs are members of the mitochondrial anion transporter family, so a reasonable hypothesis is that UCP3 might transport a small molecule such as a fatty acid anion. However, the identity of the molecule, whether the process is electrogenic, and whether UCP2 and UCP3 can also mediate proton leakage need to be determined. While the UCP2 and UCP3 sequences are quite similar, it will need to be
Other questions also beg for answers. Almost all of the regulation of UCP2 and UCP3 reported to date has been measured at the mRNA level. It seems very likely that there will be post-transcriptional regulation, to allow activity changes on a faster time scale. Thus the effects of thyroid hormone and fasting need to be measured at the protein level and, ideally, at the activity level.
Finally, what is the role of UCPs in obesity and energy metabolism? Recent data on genetic variation in humans suggesting a role in fuel usage 36 is exciting and will need to be con®rmed in independent samples from various populations. 
